目前针对高脂血症的药物研究进展 (综述)
Hanwei Zhao1, Yao Wang1, Yaqing Li2
1Peripheral Vascular Disease Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China.
Molecular medicine reports
|July 19, 2025
概括
超脂血症是一种脂质代谢障碍,由于生活方式的改变而上升,是心血管疾病的关键危险因素. 新兴疗法旨在控制胆固醇和甘油三,以预防动脉样硬化心血管疾病 (ASCVD).
科学领域:
- 脂质新陈代谢和心血管健康
- 药理学和治疗学 药理学和治疗学
背景情况:
- 在全球范围内,超脂血症的发病率正在增加,原因是生活方式因素,如饮食不良和不活动.
- 它是成人动脉样硬化心血管疾病 (ASCVD) 的重要危险因素.
- 了解脂质代谢障碍对于预防心血管疾病至关重要.
研究的目的:
- 审查脂蛋白的分类和组成.
- 讨论常见的原发性高脂血症的发病原因.
- 总结当前的降脂药物和新兴治疗方法,以预防心血管疾病.
主要方法:
- 对高脂血症分类,病因和治疗的文献综述.
- 分析初级和二级高脂血症类型的分析.
- 已确定的和新型的降脂剂的概述.
主要成果:
- 超脂血症包括初级 (例如,家族性高胆固醇血症) 和二级形式.
- 目前的治疗方法包括他类药物,ezetimibe和PCSK9抑制剂.
- 针对胆固醇和甘油三水平的新药正在开发中.
结论:
- 高脂血症的有效管理对于预防ASCVD至关重要.
- 药物治疗的进步为脂质调节提供了新的策略.
- 本综述提供了脂质代谢和治疗进展的全面概述.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
878
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Atherosclerosis III: Management
36
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
36
Overview of Lipid Metabolism
2.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
648
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
648
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Antidepressant Drugs: Overview
765
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
765


